The epidemiology of prescriptions abandoned at the pharmacy

Annals of Internal Medicine

Volumn 153, Issue 10, 2010, Pages 633-640

  Shrank, William H ^a   Choudhry, Niteesh K ^a   Fischer, Michael A ^a   Avorn, Jerry ^a   Powell, Mark ^b   Schneeweiss, Sebastian ^a   Liberman, Joshua N ^c   Dollear, Timothy ^c   Brennan, Troyen A ^c   Brookhart, M Alan ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c CVS Caremark   (United States)

^d IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; INFANT; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT ABANDONMENT; PATIENT ASSESSMENT; PHARMACY; PHARMACY BENEFIT MANAGER; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES;

EID: 78751692076     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-153-10-201011160-00005     Document Type: Article

References (28)

1. World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003. Accessed at www.who.int/chronic-conditions/en/adherence-report.pdf on 5 August 2010.
2. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002; 288:455-61. [PMID: 12132975] (Pubitemid 34787476)
3. Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998;279:1458-62. [PMID: 9600480] (Pubitemid 28228203)
4. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177-86. [PMID: 17213401] (Pubitemid 46089734)
5. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836-41. [PMID: 17000939]
6. Institute of Medicine. Initial National Priorities for Comparative Effectiveness Research. 30 June 2009. Accessed at www.iom.edu/Reports/2009/ Comparative EffectivenessResearchPriorities.aspx on 5 August 2010.
7. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007; 167:540-50. [PMID: 17389285] (Pubitemid 46513223)
8. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105-16. [PMID: 9048695]
9. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74. [PMID: 3945130]
10. Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D, et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens. 1996;9:719-25. [PMID: 8862216] (Pubitemid 26271215)
11. Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25:284-90. [PMID: 20131023]
12. Shah NR, Hirsch AG, Zacker C, Taylor S, Wood GC, Stewart WF. Factors associated with first-fill adherence rates for diabetic medications: a cohort study. J Gen Intern Med. 2009;24:233-7. [PMID: 19093157]
13. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001;154:854-64. [PMID: 11682368] (Pubitemid 33000813)
14. Soobader M, LeClere FB, Hadden W, Maury B. Using aggregate geographic data to proxy individual socioeconomic status: does size matter? Am J Public Health. 2001;91:632-6. [PMID: 11291379] (Pubitemid 32245307)
15. U.S. Census Bureau. Census 2000 Urban and Rural Classification. 2002; updated 2008. Accessed at www.census.gov/geo/www/ua/ua-2k.html on 5 August 2010.
16. Shrank WH, Cadarette SM, Cox E, Fischer MA, Mehta J, Brookhart AM, et al. Is there a relationship between patient beliefs or communication about generic drugs and medication utilization? Med Care. 2009;47:319-25. [PMID: 19194329]
17. Shrank WH, Young HN, Ettner SL, Glassman P, Asch SM, Kravitz RL. Do the incentives in 3-tier pharmaceutical benefit plans operate as intended? Results from a physician leadership survey. Am J Manag Care. 2005;11:16-22. [PMID: 15697096] (Pubitemid 40105025)
18. Shrank WH, Asch SM, Joseph GJ, Young HN, Ettner SL, Kholodenko Y, et al. Physicians' perceived knowledge of and responsibility for managing patients' out-of-pocket costs for prescription drugs. Ann Pharmacother. 2006;40:1534-40. [PMID: 16912246] (Pubitemid 44330197)
19. Choudhry NK, Avorn J, Antman EM, Schneeweiss S, Shrank WH. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. Health Aff (Millwood). 2007;26:186-94. [PMID: 17211028]
20. Chernew ME, Rosen AB, Fendrick AM. Value-based insurance design. Health Aff (Millwood). 2007;26:w195-203. [PMID: 17264100]
21. Choudhry NK, Fischer MA, Avorn J, Liberman LN, Schneeweiss S, Pakes J, et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2010. [Forthcoming].
22. Lee TJ, Fennerty MB, Howden CW. Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease? Aliment Pharmacol Ther. 2004;20:1241-51. [PMID: 15606386]
23. Grant Thornton. Cost of dispensing study. An independent comparative analysis of U.S. prescription dispensing costs. 2007. Accessed at www.rxaction.org/publications/National-COD-Study-Executive-Summary.pdf on 3 March 2010.
24. Kaiser Family Foundation. United States: prescription drugs. Accessed at www.statehealthfacts.org/profileind.jsp?sub=66&rgn=1&cat=5 on 13 March 2010.
25. Gellad WF, Choudhry NK, Friedberg MW, Brookhart MA, Haas JS, Shrank WH. Variation in drug prices at pharmacies: are prices higher in poorer areas? Health Serv Res. 2009;44:606-17. [PMID: 19178584]
26. Geronimus AT, Bound J. Use of census-based aggregate variables to proxy for socioeconomic group: evidence from national samples. Am J Epidemiol. 1998;148:475-86. [PMID: 9737560] (Pubitemid 28411105)
27. Goldman DP, Joyce GF, Escarce JJ, Pace JE, Solomon MD, Laouri M, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291:2344-50. [PMID: 15150206] (Pubitemid 38656301)
28. Shrank WH, Hoang T, Ettner SL, Glassman PA, Nair K, DeLapp D, et al. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med. 2006; 166:332-7. [PMID: 16476874] (Pubitemid 43244321)